DarioHealth, with apps for managing chronic diseases, will acquire mental health...
A NIH study of myalgic encephalomyelitis, or chronic fatigue syndrome, points to...
In utero gene editing envisions treating a fetus diagnosed with a genetic diseas...
Medicare funding should be distributed based on need, not unequal territorial st...
Tippi MacKenzie envisions doing surgery without scalpels or sutures, editing fet...
RioDerm-001 is under clinical development by Rion and currently in Phase II for ...
SY-001 is under clinical development by CellOrigin Technology (Hangzhou) and cur...
Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and C...
RioDerm-004 is under clinical development by Rion and currently in Phase I for F...
Ketamine is under clinical development by NRX Pharmaceuticals and currently in P...
SAR-442970 is under clinical development by Sanofi and currently in Phase II for...
NA-921 is under clinical development by Biomed Industries and currently in Phase...
NA-921 is under clinical development by Biomed Industries and currently in Phase...
PF-07872412 is under clinical development by Pfizer and currently in Phase I for...
INV-347 is under clinical development by Inversago Pharma and currently in Phase...
Although people of European descent account for less than one-quarter of the wor...
